Company profile · free preview
Lycia Therapeutics Inc.
LYCA · NASDAQ · Healthcare · Updated 11/12/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Lycia Therapeutics Inc.'s filings — free.
Create free accountLycia Therapeutics Inc. insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-11-02 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 8,305 | $26.95 |
| 2026-10-30 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 200 | $26.86 |
| 2026-10-30 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 8,804 | $26.27 |
| 2026-10-29 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 1,000 | $26.33 |
| 2026-10-28 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 4,430 | $25.97 |
| 2026-10-28 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 10,570 | $25.23 |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 31,067 | $26.84 |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 8,729 | $25.84 |
SEC filings
Ask anything about Lycia Therapeutics Inc.'s filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching free